Group 1 - The company held the 19th temporary meeting of the 9th board on December 2, 2025, where it approved the amendments to the Articles of Association and the formulation and revision of certain governance systems [1][36] - The amendments to the Articles of Association are based on relevant laws and regulations, and the specific content will be adjusted according to the approval of the registration authority [1][2] - Other provisions in the Articles of Association will remain unchanged, and the amendments require approval from the shareholders' meeting with a special resolution [2] Group 2 - The company aims to improve its governance structure by formulating and revising certain governance systems in accordance with relevant laws and regulations [3] - Specific governance systems that have been approved by the board include the management system for the departure of directors and senior management, the information disclosure deferral and exemption system, and the work rules for the general manager [3] - Some governance systems, such as the remuneration management system for directors and senior management, require approval from the upcoming shareholders' meeting [3] Group 3 - The company plans to hold the 4th temporary shareholders' meeting on December 22, 2025, at 14:00, combining on-site and online voting [5][7] - The meeting will be held at the company's conference room located at No. 9, Health Road, Yangzhou Biohealth Industry Park [7] - Shareholders can vote through the Shanghai Stock Exchange's online voting system during specified time slots on the day of the meeting [8] Group 4 - The company has proposed to reappoint Zhonghui Certified Public Accountants as the auditor for the 2025 financial year, with an audit fee of RMB 950,000, which represents a 26.67% increase compared to the previous year [22][30] - The audit committee of the board has reviewed and agreed to the reappointment, stating that the firm has maintained independence and fulfilled its auditing responsibilities [31][32] - The reappointment of the accounting firm also requires approval from the shareholders' meeting [32]
江苏联环药业股份有限公司关于修订《公司章程》及修订、制定部分治理制度的公告